Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 456

1.

Risk and management of upper gastrointestinal bleeding associated with prolonged dual-antiplatelet therapy after percutaneous coronary intervention.

Tan VP, Yan BP, Kiernan TJ, Ajani AE.

Cardiovasc Revasc Med. 2009 Jan-Mar;10(1):36-44. doi: 10.1016/j.carrev.2008.11.001. Review.

PMID:
19159853
2.

Significant gastrointestinal bleeding in patients at risk of coronary stent thrombosis.

Dai X, Makaryus AN, Makaryus JN, Jauhar R.

Rev Cardiovasc Med. 2009 Winter;10(1):14-24. Review.

PMID:
19367228
3.

Antiplatelet therapy discontinuation following drug-eluting stent placement: dangers, reasons, and management recommendations.

Moussa ID, Colombo A.

Catheter Cardiovasc Interv. 2009 Dec 1;74(7):1047-54. doi: 10.1002/ccd.22167. Review.

PMID:
19626692
4.

Individualized antithrombotic therapy in high risk patients after coronary stenting. A double-edged sword between thrombosis and bleeding.

May AE, Geisler T, Gawaz M.

Thromb Haemost. 2008 Mar;99(3):487-93. doi: 10.1160/TH07-11-0680. Review.

PMID:
18327396
5.

Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.

Aronow HD, Steinhubl SR, Brennan DM, Berger PB, Topol EJ; CREDO Investigators.

Am Heart J. 2009 Feb;157(2):369-74. doi: 10.1016/j.ahj.2008.09.011. Epub 2008 Nov 1.

PMID:
19185647
6.

Noncardiac surgery and bleeding after percutaneous coronary intervention.

To AC, Armstrong G, Zeng I, Webster MW.

Circ Cardiovasc Interv. 2009 Jun;2(3):213-21. doi: 10.1161/CIRCINTERVENTIONS.108.830158. Epub 2009 Apr 21.

7.

Gastrointestinal bleeding after percutaneous coronary intervention.

Tanigawa T, Watanabe T, Nadatani Y, Otani K, Machida H, Okazaki H, Yamagami H, Watanabe K, Tominaga K, Fujiwara Y, Arakawa T.

Digestion. 2011;83(3):153-60. doi: 10.1159/000321813. Epub 2011 Jan 21. Review.

PMID:
21266809
8.

Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation.

Helft G, Gilard M, Le Feuvre C, Zaman AG.

Nat Clin Pract Cardiovasc Med. 2006 Dec;3(12):673-80. Review.

PMID:
17122800
9.

[Dual antithrombotic therapy after implantation of coronary stents].

Schneider H, Weber F, Holzhausen C, Körber T, Ince H, Rehders T, Nienaber CA.

Dtsch Med Wochenschr. 2006 May 12;131(19):1105-10. Review. German.

PMID:
16685632
10.
11.

[Bleeding or stent thrombosis in combination with drug-eluting stents].

Jensen MK, Hüttel M.

Ugeskr Laeger. 2009 Feb 23;171(9):718. Danish.

PMID:
19258000
12.

Incidence of stent thrombosis in patients with drug eluting stents and short-term dual antiplatelet therapy.

Steinwender C, Hartenthaler B, Lambert T, Kypta A, Kammler J, Hönig S, Hofmann R, Kerschner K, Leisch F.

EuroIntervention. 2009 Mar;4(5):593-9.

PMID:
19378679
13.

[Dual platelet aggregation inhibition in coronary artery stent implantation--what is evidence-based?].

Baer FM, Erdmann E.

Dtsch Med Wochenschr. 2007 Jun 8;132(23):1275-80. Review. German.

PMID:
17541871
14.

Prolonged dual antiplatelet therapy improves clinical outcomes in high-risk patients implanted with sirolimus-eluting stents.

Dean J, Yujie Z, Yingxin Z, Yuyang L, Yonghe G, Wanjun C, Zheng C.

Clin Cardiol. 2009 Mar;32(3):164-8. doi: 10.1002/clc.20307.

15.

Bridging therapy in the perioperative management of patients with drug-eluting stents.

Chou S, Eshaghian S, Lamer A, Tran H, Dohad S, Kaul S.

Rev Cardiovasc Med. 2009 Fall;10(4):209-18.

PMID:
20065931
16.

Upper gastrointestinal bleeding in patients receiving dual antiplatelet therapy after coronary stenting.

Yasuda H, Yamada M, Sawada S, Endo Y, Inoue K, Asano F, Takeyama Y, Yoshiba M.

Intern Med. 2009;48(19):1725-30. Epub 2009 Oct 1.

17.

Deciphering dual antiplatelet therapy in the era of drug-eluting coronary stents.

Bell B, Walters D, Spaulding C.

Curr Drug Targets. 2009 Jun;10(6):519-29. Review.

PMID:
19519354
18.
19.

Impact of "nuisance" bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation.

Roy P, Bonello L, Torguson R, de Labriolle A, Lemesle G, Slottow TL, Steinberg DH, Kaneshige K, Xue Z, Satler LF, Kent KM, Suddath WO, Pichard AD, Lindsay J, Waksman R.

Am J Cardiol. 2008 Dec 15;102(12):1614-7. doi: 10.1016/j.amjcard.2008.07.063. Epub 2008 Sep 27.

PMID:
19064014
20.

Potential Interaction between clopidogrel and proton pump inhibitors.

Howard PA, Vacek JL.

Am J Cardiovasc Drugs. 2009;9(6):353-9. doi: 10.2165/11317990-000000000-00000.

PMID:
19929033

Supplemental Content

Support Center